Impact of Immunohistochemistry-Based Molecular Subtype on Chemosensitivity and Survival in Patients with Breast Cancer Following Neoadjuvant Chemotherapy

PURPOSE: Pathologic complete response (pCR) has been suggested as a surrogate prognostic indicator in breast cancer patients treated with neoadjuvant chemotherapy. We assessed whether the likelihood of pCR and survival is associated with the immunohistochemistry-based molecular subtypes. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Changhoon, Ahn, Jin-Hee, Jung, Kyung Hae, Kim, Sung-Bae, Kim, Hak-Hee, Shin, Hee Jung, Ahn, Sei Hyun, Son, Byung Ho, Gong, Gyungyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395744/
https://www.ncbi.nlm.nih.gov/pubmed/22807938
http://dx.doi.org/10.4048/jbc.2012.15.2.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395744/
https://www.ncbi.nlm.nih.gov/pubmed/22807938
http://dx.doi.org/10.4048/jbc.2012.15.2.203

Ejemplares similares